Wedbush analyst Seth Basham maintained a Buy rating on RumbleON (RMBL – Research Report) today and set a price target of $5.00. The company’s ...

However, Wedbush’s team said Musk has a good track record of balancing multiple initiatives and accelerating innovation at Tesla. Put simply, Wedbush views these as containable brand issues that ...

Check Out Our Latest Analysis on Arcus Biosciences Arcus Biosciences Trading Up 3.0 % NYSE:RCUS opened at $11.06 on Friday. The company has a 50-day moving average price of $13.92 and a 200-day ...

Investing.com -- Tesla's stock has faced continued pressure in 2025, but Wedbush analysts remain bullish, maintaining their Outperform rating and $550 price target on the stock. While concerns ...

Wedbush analyst Dan Ives has been one of the early backers of Palantir. Safe to say, his pick has been a success. Now, as Ives continues to remain bullish on the company, he is eyeing another ...

Wedbush made a splash on Tuesday with the announcement that it was entering the ever-growing exchange-traded fund market. With more than 7K ETFs listed globally, collectively managing over $10T in ...

Wedbush Securites, a 70-year-old financial services firm based in Los Angeles, has filed with the Securities and Exchange Commission to enter the ETF space. According to the filing, the proposed ...

Wedbush will sponsor its own ETFs to provide clients and investors with cost-effective, transparent investment options designed to meet modern portfolio construction needs. “ETF creation is a ...

Wedbush will sponsor its own ETFs to provide clients and investors with cost-effective, transparent investment options designed to meet modern portfolio construction needs. “ETF creation is a logical ...